# Ryota Shintani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ryota-shintani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 268 |
| Field | Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| h-index | 7 |
| i10-index | 7 |
| Last Known Institution | NHO Kinki Chuo Chest Medical Center |
| OpenAlex ID | https://openalex.org/A5003838681 |
| Works | 65 |

## Researcher papers

- [Predictive Factors for the Long-Term Deterioration of Pulmonary Function in Interstitial Lung Disease Associated with Anti-Aminoacyl-tRNA Synthetase Antibodies](https://scholariq.org/papers/predictive-factors-for-the-long-term-deterioration-of-pulmonary-function-in/)
- [Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial](https://scholariq.org/papers/long-term-effect-of-pulmonary-rehabilitation-in-idiopathic-pulmonary-fibrosis-a/)
- [Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases](https://scholariq.org/papers/outcome-of-early-stage-combination-treatment-with-favipiravir-and/)
- [Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis](https://scholariq.org/papers/negative-impact-of-anorexia-and-weight-loss-during-prior-pirfenidone/)
- [Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019](https://scholariq.org/papers/serum-krebs-von-den-lungen-6-levels-are-associated-with-mortality-and-severity/)
- [Low starting-dosage of nintedanib for the reduction of early termination](https://scholariq.org/papers/low-starting-dosage-of-nintedanib-for-the-reduction-of-early-termination/)
- [Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration](https://scholariq.org/papers/randomized-phase-ii-study-of-nintedanib-with-or-without-pirfenidone-in-patients/)
- [A case of relapsed lung abscess caused by Eubacterium brachy infection following an initial diagnosis of pulmonary actinomycosis](https://scholariq.org/papers/a-case-of-relapsed-lung-abscess-caused-by-eubacterium-brachy-infection-following/)
- [Transbronchial lung cryobiopsy in idiopathic acute fibrinous and organizing pneumonia](https://scholariq.org/papers/transbronchial-lung-cryobiopsy-in-idiopathic-acute-fibrinous-and-organizing/)
- [Clinical characteristics of Japanese patients with moderate to severe COVID-19](https://scholariq.org/papers/clinical-characteristics-of-japanese-patients-with-moderate-to-severe-covid-19/)
- [Re-biopsy of twelve non small cell lung cancer (NSCLC) cases](https://scholariq.org/papers/re-biopsy-of-twelve-non-small-cell-lung-cancer-nsclc-cases/)

## Researcher topics

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Crystallization and Solubility Studies](https://scholariq.org/topics/crystallization-and-solubility-studies/)
- [X-ray Diffraction in Crystallography](https://scholariq.org/topics/x-ray-diffraction-in-crystallography/)
- [Medical Imaging and Pathology Studies](https://scholariq.org/topics/medical-imaging-and-pathology-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Researcher university

- [NHO Kinki Chuo Chest Medical Center](https://scholariq.org/institutions/nho-kinki-chuo-chest-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.